Medicine
Pryidostigmine Bromide 60 mg/5 mL oral solution
Pryidostigmine Bromide 60 mg/5 mL oral solution is a prescription medicine containing Pyridostigmine for oral use, marketed by Rising Pharma Holdings, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store pyridostigmine bromide oral solution USP at 25°C (77°F), excursions…
Key facts
- Active ingredient (INN)
- Pyridostigmine
- Brand
- Pryidostigmine Bromide
- Strength
- 60 mg/5 mL
- Dosage form
- Oral solution
- Route
- Oral
- Packs
- 473 mL
- Marketing authorisation holder
- Rising Pharma Holdings
- Manufacturers
- Rising Pharma HoldingsApnar Pharma
- Origin register
- US FDA, United States
- Storage
- Store pyridostigmine bromide oral solution USP at 25°C (77°F), excursions permitted to 15°-30°C (59°-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N07AA02 Pyridostigmine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 September 2022
- Identifiers
- RxCUI 903843DailyMed set ID beda905e-005a-439d-ac74-92db4e269780, d42f2d2e-b9f8-7c22-e053-2995a90a9661NDC 16571-833, 24689-104Application ANDA208797
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 473 mL in 1 bottle, plastic | 16571-833-16 | Rising Pharma Holdings | 15 September 2022 |
| 473 mL in 1 bottle, plastic | 24689-104-01 | Apnar Pharma | 1 June 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 6 April 1955 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Pyridostigmine 60 mg/5 mL oral solution.
Other strengths and forms of Pyridostigmine
Clinical summary
Pyridostigmine is a cholinesterase inhibitor. It is available as tablets, oral solution and extended-release tablets for intravenous and parenteral use. MedsAcross supplies Pyridostigmine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PyridostigmineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Mestinon prescribing information (Bausch Health) · U.S. National Library of Medicine, DailyMed
Need Pryidostigmine Bromide 60 mg/5 mL oral solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.